Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

20.78p
   
  • Change Today:
      0.97p
  • 52 Week High: 212.60
  • 52 Week Low: 18.46
  • Currency: UK Pounds
  • Shares Issued: 201.37m
  • Volume: 116,708
  • Market Cap: £41.85m
  • RiskGrade: 510

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
1.14% below the market average1.14% below the market average1.14% below the market average1.14% below the market average1.14% below the market average
49.09% above the sector average49.09% above the sector average49.09% above the sector average49.09% above the sector average49.09% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
46.09% below the market average46.09% below the market average46.09% below the market average46.09% below the market average46.09% below the market average
15.62% below the sector average15.62% below the sector average15.62% below the sector average15.62% below the sector average15.62% below the sector average
Price Chg 3m
91.58% below the market average91.58% below the market average91.58% below the market average91.58% below the market average91.58% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
40.51% above the market average40.51% above the market average40.51% above the market average40.51% above the market average40.51% above the market average
27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average
Momentum 20
3.15% above the market average3.15% above the market average3.15% above the market average3.15% above the market average3.15% above the market average
1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.91% below the market average91.91% below the market average91.91% below the market average91.91% below the market average91.91% below the market average
78.57% below the sector average78.57% below the sector average78.57% below the sector average78.57% below the sector average78.57% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
95.35% below the market average95.35% below the market average95.35% below the market average95.35% below the market average95.35% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
14.74% above the market average14.74% above the market average14.74% above the market average14.74% above the market average14.74% above the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average
Cash
38.02% above the market average38.02% above the market average38.02% above the market average38.02% above the market average38.02% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
71.24% below the market average71.24% below the market average71.24% below the market average71.24% below the market average71.24% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 20.78p
Change Today 0.97p
% Change 4.87 %
52 Week High 212.60
52 Week Low 18.46
Volume 116,708
Shares Issued 201.37m
Market Cap £41.85m
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.00% above the market average34.00% above the market average34.00% above the market average34.00% above the market average34.00% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average
Price Trend
77.77% below the market average77.77% below the market average77.77% below the market average77.77% below the market average77.77% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 26-Sep-2022

Time Volume / Share Price
16:10 679 @ 20.78p
15:50 240 @ 20.78p
15:50 2,638 @ 20.78p
15:50 58 @ 20.78p
15:50 56 @ 20.78p

Synairgen Key Personnel

CEO Richard J Marsden
Finance Director John C Ward

Top of Page